The Board of Directors of iNtRON Biotechnology, Inc. has authorized a buyback plan on December 2, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,230 KRW | +2.13% | +3.83% | -29.04% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.04% | 151M | |
+15.55% | 121B | |
+12.66% | 107B | |
-2.53% | 24.82B | |
+0.87% | 22.48B | |
-9.58% | 18.32B | |
-42.28% | 16.33B | |
-18.92% | 15.31B | |
+6.19% | 14.08B | |
+28.83% | 11.74B |
- Stock Market
- Equities
- A048530 Stock
- News iNtRON Biotechnology, Inc.
- INtRON Biotechnology, Inc. authorizes a Buyback Plan.